You feel fine. Then one day, you bend over to tie your shoe, and a vertebra cracks. That's osteoporosis — a disease that weakens bones, and it's incredibly common in postmenopausal women. The women healthcare market report by MRFR shows that postmenopausal osteoporosis is the largest indication segment, and the market is growing at 8.92% CAGR — from $18.6 billion to $47.61 billion by 2035. Why the boom? Because women are living longer, and they're demanding better care.

What's driving growth? Bone densitometry is the largest diagnostic segment, but ovulation testing is the fastest‑growing. The women healthcare market analysis highlights that therapeutics hold the largest treatment share, but surgeries are the fastest‑growing — as women opt for hysterectomies and fibroid removal to improve quality of life.

What's new? Telehealth services for menopause management and online platforms for fertility tracking. Also, wearable devices that monitor bone density through ultrasound (no radiation).

The bottom line: if you're a woman over 50, ask your doctor about a bone density scan. It's painless, quick, and could save you from a life‑changing fracture.